According to the latest report by IMARC Group the global vaccine market size reached a strong growth in 2020.One of the leading trends witnessed in the global vaccines market is the surging cases of the coronavirus disease (COVID-19), which has, till date, resulted in the loss of around half a million lives around the world Looking forward, the market value is projected to reach a strong growth during the forecast period (2021-2026).
2. Report Description
About IMARC Group
The International Market Analysis Research and Consulting Group is a leading adviser on
management strategy and market research worldwide. We partner with clients in all sectors
and regions to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our
clients achieve unmatchable competitive advantage, build more proficient organizations, and
secure lasting results.
3. Report Description
Report Description and Highlights
GLOBAL Vaccine Market Research Report:
According to the latest report by IMARC Group, titled “Vaccine Market: Global Industry Trends, Share,
Size, Growth, Opportunity and Forecast 2021-2026,” the global vaccine market size reached a strong
growth in 2020.
A vaccine refers to a biological preparation made using the weakened form of the disease-causing
microorganism.
It is injected to stimulate the production of antibodies against several pathogens present in the body.
Moreover, it helps to prevent life-threatening diseases, such as polio, measles, diphtheria, meningitis,
influenza, tetanus, rotavirus and hepatitis.
Consequently, vaccines are increasingly being utilized in hospitals, clinics and vaccination centers
worldwide. They are also widely adopted for research and development (R&D) purposes in academic
setups and clinical laboratories across the globe.
Request Free Sample Report: https://www.imarcgroup.com/vaccine-market/requestsample
4. Report Description
Report Description and Highlights
Global Vaccine Market Trends :
One of the leading trends witnessed in the global vaccines market is the surging cases of the
coronavirus disease (COVID-19), which has, till date, resulted in the loss of around half a million lives
around the world.
As a result, several pharmaceutical companies are currently engaged in extensive research and
development (R&D) activities to introduce a novel vaccine against the disease. Apart from this, the
World Health Organization (WHO) is undertaking the initiative of increasing awareness about
immunization through the Global Vaccine Action Plan (GVAP) and Global Immunization Vision and
Strategy (GIVS).
Moreover, the high prevalence of infectious diseases and R&D activities pertaining to the immunization
of several fatal diseases, such as Acquired Immunodeficiency Syndrome (AIDS), Ebola, Hepatitis C and
paratyphoid fever, are also propelling the market growth.
Looking forward, the market value is projected to reach a strong growth during the forecast period
(2021-2026).
5. Report Description
Report Description and Highlights
Market Summary:
Breakup by Technology :
• conjugate
• inactivated
• subunit
• live attenuated
• recombinant
• toxoid
Breakup By Product Type:
• Multivalent vaccines
• Monovalent vaccines.
Breakup by Treatment type:
• Preventive vaccines
• Therapeutic vaccines
6. Breakup by Distribution:
• Hospital pharmacies
• Retail pharmacies
• Institutional sales.
Breakup by Region:
• North Ameriac
• Asia Pacific
• Europe
• Latin America
• Middle East and Afric
Furthermore, the growing government support for vaccine development and the increasing
involvement of global organizations in the development of adequate vaccination facilities in endemic
regions is anticipated to positively influencing the sales of vaccines in the upcoming years.
Note: We are updating our research report 2021-2026. If you want to need latest primary and
secondary data with Cost Module, Business Strategy, Distribution Channel, etc.
Report Description
Report Description and Highlights
7. Competitive Landscape with Key Player:
• Abbott Laboratories
• Astellas Pharma Inc.
• AstraZeneca Plc
• Bharat Biotech International Limited
• Bavarian Nordic A/S, CSL Limited, Daiichi Sankyo Company
• Limited, Emergent BioSolutions Inc.
• GlaxoSmithKline Plc
• Inovio Pharmaceuticals Inc.
• Johnson & Johnson
• Inc., Merck & Co. Inc.
• Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation)
• Novavax Inc.
View Full Customization Report with TOC and List of figure :https://www.imarcgroup.com/vaccine-
market
Report Description
Report Description and Highlights
8. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients
9. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients